Börje J Ljungberg

Summary

Country: Sweden

Publications

  1. pmc Gene expression pattern of the epidermal growth factor receptor family and LRIG1 in renal cell carcinoma
    Marcus Thomasson
    Department of Radiation Sciences, Umea University, SE 901 87, Umea, Sweden
    BMC Res Notes 5:216. 2012
  2. doi request reprint The role of metastasectomy in renal cell carcinoma in the era of targeted therapy
    Borje Ljungberg
    Department of Surgical and Perioperative Sciences, Urology and Andrology, Umea University, Umea, Sweden
    Curr Urol Rep 14:19-25. 2013
  3. pmc High-resolution DNA copy number and gene expression analyses distinguish chromophobe renal cell carcinomas and renal oncocytomas
    Maria V Yusenko
    Laboratory of Molecular Oncology, Medical Faculty, Ruprecht Karls University, Heidelberg, Germany
    BMC Cancer 9:152. 2009
  4. doi request reprint EAU guidelines on renal cell carcinoma: the 2010 update
    Borje Ljungberg
    Department of Surgical and Perioperative Sciences, Urology and Andrology, Umea University, Umea, Sweden
    Eur Urol 58:398-406. 2010
  5. ncbi request reprint Prognostic factors in renal cell carcinoma
    B Ljungberg
    Department of Surgical and Perioperative Sciences, Urology and Andrology, Umea University, Umea, Sweden
    Scand J Surg 93:118-25. 2004
  6. ncbi request reprint Nephron-sparing surgery--strategies for partial nephrectomy in renal cell carcinoma
    B Ljungberg
    Department of Surgical and Perioperative Sciences, Urology and Andrology, Umea University, Umea, Sweden
    Scand J Surg 93:126-31. 2004
  7. ncbi request reprint Different vascular endothelial growth factor (VEGF), VEGF-receptor 1 and -2 mRNA expression profiles between clear cell and papillary renal cell carcinoma
    Börje J Ljungberg
    Urology and Andrology, Department of Surgical and Perioperative Sciences, Umea University, Umea, Sweden
    BJU Int 98:661-7. 2006
  8. ncbi request reprint Renal cell carcinoma guideline
    Borje Ljungberg
    Department of Surgical and Perioperative Sciences, Urology and Andrology, Umea University, Umea, Sweden, and Department of Urology, Lister Hospital, Stevenage, UK
    Eur Urol 51:1502-10. 2007
  9. ncbi request reprint Prognostic markers in renal cell carcinoma
    Borje Ljungberg
    Department of Surgical and Perioperative Sciences, Urology and Andrology, Umea University, Umea, Sweden
    Curr Opin Urol 17:303-8. 2007
  10. doi request reprint The epidemiology of renal cell carcinoma
    Borje Ljungberg
    Department of Surgical and Perioperative Sciences, Urology and Andrology, Umea University, Umea, Sweden
    Eur Urol 60:615-21. 2011

Collaborators

Detail Information

Publications33

  1. pmc Gene expression pattern of the epidermal growth factor receptor family and LRIG1 in renal cell carcinoma
    Marcus Thomasson
    Department of Radiation Sciences, Umea University, SE 901 87, Umea, Sweden
    BMC Res Notes 5:216. 2012
    ..In this study, we analyzed the gene expression levels of EGFR-family members and LRIG1, and their possible associations with clinical parameters in various types of RCC...
  2. doi request reprint The role of metastasectomy in renal cell carcinoma in the era of targeted therapy
    Borje Ljungberg
    Department of Surgical and Perioperative Sciences, Urology and Andrology, Umea University, Umea, Sweden
    Curr Urol Rep 14:19-25. 2013
    ..Patients with metastatic renal cell carcinoma should be considered for multimodal therapy, including surgery of metastatic lesions. A proportion of patients will achieve long-term survival with aggressive surgical resection...
  3. pmc High-resolution DNA copy number and gene expression analyses distinguish chromophobe renal cell carcinomas and renal oncocytomas
    Maria V Yusenko
    Laboratory of Molecular Oncology, Medical Faculty, Ruprecht Karls University, Heidelberg, Germany
    BMC Cancer 9:152. 2009
    ..The diagnosis of benign renal oncocytomas (RO) and chromophobe renal cell carcinomas (RCC) based on their morphology remains uncertain in several cases...
  4. doi request reprint EAU guidelines on renal cell carcinoma: the 2010 update
    Borje Ljungberg
    Department of Surgical and Perioperative Sciences, Urology and Andrology, Umea University, Umea, Sweden
    Eur Urol 58:398-406. 2010
    ....
  5. ncbi request reprint Prognostic factors in renal cell carcinoma
    B Ljungberg
    Department of Surgical and Perioperative Sciences, Urology and Andrology, Umea University, Umea, Sweden
    Scand J Surg 93:118-25. 2004
  6. ncbi request reprint Nephron-sparing surgery--strategies for partial nephrectomy in renal cell carcinoma
    B Ljungberg
    Department of Surgical and Perioperative Sciences, Urology and Andrology, Umea University, Umea, Sweden
    Scand J Surg 93:126-31. 2004
    ..Albeit these facts, there is convincing evidence justifying nephron-sparing surgery to be used routinely for patients with a small renal cell carcinoma and a normal functioning contralateral kidney...
  7. ncbi request reprint Different vascular endothelial growth factor (VEGF), VEGF-receptor 1 and -2 mRNA expression profiles between clear cell and papillary renal cell carcinoma
    Börje J Ljungberg
    Urology and Andrology, Department of Surgical and Perioperative Sciences, Umea University, Umea, Sweden
    BJU Int 98:661-7. 2006
    ....
  8. ncbi request reprint Renal cell carcinoma guideline
    Borje Ljungberg
    Department of Surgical and Perioperative Sciences, Urology and Andrology, Umea University, Umea, Sweden, and Department of Urology, Lister Hospital, Stevenage, UK
    Eur Urol 51:1502-10. 2007
    ....
  9. ncbi request reprint Prognostic markers in renal cell carcinoma
    Borje Ljungberg
    Department of Surgical and Perioperative Sciences, Urology and Andrology, Umea University, Umea, Sweden
    Curr Opin Urol 17:303-8. 2007
    ..This article reviews recent reports on prognostic markers in renal cell carcinoma...
  10. doi request reprint The epidemiology of renal cell carcinoma
    Borje Ljungberg
    Department of Surgical and Perioperative Sciences, Urology and Andrology, Umea University, Umea, Sweden
    Eur Urol 60:615-21. 2011
    ..Globally, about 270 000 cases of kidney cancer are diagnosed yearly and 116 000 people die from the disease. Approximately 90% of all kidney cancers are renal cell carcinomas (RCC)...
  11. ncbi request reprint Contemporary status of open nephron-sparing surgery in renal cell carcinoma
    Borje Ljungberg
    Department of Surgical and Perioperative Sciences, Urology and Andrology, Umea University, Sweden
    Arch Ital Urol Androl 81:61-4. 2009
    ....
  12. ncbi request reprint Tumour vascular endothelial growth factor (VEGF) mRNA in relation to serum VEGF protein levels and tumour progression in human renal cell carcinoma
    Borje Ljungberg
    Department of Surgical and Perioperative Sciences, Umea University, 90185 Umea, Sweden
    Urol Res 31:335-40. 2003
    ..The association with tumour progression shows that VEGF is a promising angiogenic factor especially important in conventional RCCs. VEGF expression might possibly be of help to identify RCCs susceptible for anti-angiogenic therapies...
  13. ncbi request reprint p53 expression in correlation to clinical outcome in patients with renal cell carcinoma
    B Ljungberg
    Department of Surgical and Perioperative Sciences, Urology and Andrology, Umea University, Sweden
    Scand J Urol Nephrol 35:15-20. 2001
    ..The aim of this study was to evaluate the role of p53 as prognostic factor in renal cell carcinoma (RCC) and its relation to clinicopathological factors...
  14. ncbi request reprint Factors of importance for prediction of survival in patients with metastatic renal cell carcinoma, treated with or without nephrectomy
    B Ljungberg
    Department of Surgical and Perioperative Science, Urology and Andrology, Umea University, Sweden
    Scand J Urol Nephrol 34:246-51. 2000
    ..A number of variables were analysed to identify factors that might predict the survival time, and these factors were used to obtain guidance as to which patients might benefit from palliative nephrectomy...
  15. ncbi request reprint Follow-up guidelines for nonmetastatic renal cell carcinoma based on the occurrence of metastases after radical nephrectomy
    B Ljungberg
    Department of Urology, Umea University, Umea, Sweden
    BJU Int 84:405-11. 1999
    ..To define guidelines for the follow-up management of nonmetastatic renal cell carcinoma (RCC), by assessing tumour recurrences and the clinical course in patients who had undergone radical nephrectomy...
  16. ncbi request reprint Impact of serum basic fibroblast growth factor on prognosis in human renal cell carcinoma
    T Rasmuson
    Department of Radiation Sciences, Oncology, Umea University, Sweden
    Eur J Cancer 37:2199-203. 2001
    ..001). Furthermore, patients with tumours with vein invasion had a worse prognosis compared with those without invasion. After multivariate analysis, only tumour stage and grade remained as independent prognostic factors...
  17. ncbi request reprint Prognostic significance of the Heidelberg classification of renal cell carcinoma
    B Ljungberg
    Department of Urology and Andrology, Umea University, Umea, Sweden
    Eur Urol 36:565-9. 1999
    ..In a large material of patients, the prognostic and clinical information of these different tumour types were evaluated...
  18. ncbi request reprint Serum beta 2-microglobulin and prognosis of patients with renal cell carcinoma
    T Rasmuson
    Department of Oncology, , Sweden
    Acta Oncol 35:479-82. 1996
    ..Weaker factors were age and cell type, whereas the prognostic value of serum beta 2-M disappeared. However, if tumour cell type was excluded from the analysis, serum beta 2-M was identified as a prognostic factor...
  19. pmc Expression of cyclin D1, D3, E, and p27 in human renal cell carcinoma analysed by tissue microarray
    Y Hedberg
    Department of Medical Biosciences, Pathology, Umea University, Umea, Sweden
    Br J Cancer 88:1417-23. 2003
    ..In summary, we have shown that G1/S regulatory defects are present in RCC and are associated with clinico-pathological parameters. The pattern of cell cycle regulatory defects also differed between RCC subtypes...
  20. ncbi request reprint Expression of vascular endothelial growth factor protein in human renal cell carcinoma
    J Jacobsen
    Department of Surgical and Perioperative Sciences, Urology and Andrology, Umea University, Umea, Sweden
    BJU Int 93:297-302. 2004
    ....
  21. doi request reprint Sentinel node detection in renal cell carcinoma. A feasibility study for detection of tumour-draining lymph nodes
    Amir M Sherif
    Department of Urology, Karolinska University Hospital, Stockholm, Sweden
    BJU Int 109:1134-9. 2012
    ..To evaluate the feasibility of performing sentinel node detection in patients with renal cell carcinoma (RCC)...
  22. ncbi request reprint Cyclin-D1 expression in human renal-cell carcinoma
    Y Hedberg
    Department of Pathology, Umea University, Sweden
    Int J Cancer 84:268-72. 1999
    ..005 and 0.002 respectively), as compared with highly aggressive tumours with low cyclin-D1 levels...
  23. ncbi request reprint Neuroendocrine differentiation in renal cell carcinoma--evaluation of chromogranin A and neuron-specific enolase
    T Rasmuson
    Department of Oncology, Umea University, Sweden
    Acta Oncol 38:623-8. 1999
    ..In a multivariate analysis, tumour stage, grade, and serum NSE, but not chromogranin A, were significant predictors of prognosis...
  24. ncbi request reprint Prognostic importance of serum vascular endothelial growth factor in relation to platelet and leukocyte counts in human renal cell carcinoma
    J Jacobsen
    Department of Surgical and Perioperative Sciences, Urology and Andrology, Umea University, S 901 85 Umea, Sweden
    Eur J Cancer Prev 11:245-52. 2002
    ..Only stage and grade remained as independent prognostic factors. Both VEGF levels and platelet counts gave prognostic information but VEGF was more reliable as predictor of survival in patients with RCC...
  25. ncbi request reprint Increased serum cortisol levels are associated with high tumour grade in patients with renal cell carcinoma
    T Rasmuson
    Department of Radiation Sciences, Oncology, Umea University, Sweden
    Acta Oncol 40:83-7. 2001
    ..In a multivariate analysis, disease stage and tumour grade were independent predictors of prognosis. Age, gender and serum levels of cortisol and DHEAS were of limited value for prognosis...
  26. ncbi request reprint Diagnosis of renal cell carcinoma by bone marrow aspiration biopsy
    B Ljungberg
    Department of Surgical and Perioperative Science, Urology and Andrology, Umea University, Sweden
    Scand J Urol Nephrol 35:334-6. 2001
    ..A computerized tomography confirmed the diagnosis. The patient progressed rapidly and died of widespread metastatic papillary renal cell carcinoma...
  27. pmc LRIG1 and epidermal growth factor receptor in renal cell carcinoma: a quantitative RT--PCR and immunohistochemical analysis
    M Thomasson
    Department of Radiation Sciences, Oncology, Umea University Hospital, Umea, Sweden
    Br J Cancer 89:1285-9. 2003
    ..Further studies are justified to elucidate the explicit role of LRIG1 in the oncogenesis of RCC...
  28. pmc Soluble ectodomain of c-erbB-2 oncoprotein in relation to tumour stage and grade in human renal cell carcinoma
    T Rasmuson
    Department of Oncology, , Sweden
    Br J Cancer 75:1674-7. 1997
    ..003). In a multivariate analysis, c-erbB-2 oncoprotein lost its prognostic information, while tumour stage and tumour grade were identified as independent prognostic factors...
  29. pmc Wilms' tumour 1 can suppress hTERT gene expression and telomerase activity in clear cell renal cell carcinoma via multiple pathways
    R T Sitaram
    Department of Medical Biosciences and Pathology, Umea University, Umea, Sweden
    Br J Cancer 103:1255-62. 2010
    ..Wilms' tumour 1 (WT1) gene was discovered as a tumour suppressor gene. Later findings have suggested that WT1 also can be oncogenic. This complexity is partly explained by the fact that WT1 has a number of target genes...
  30. ncbi request reprint Excretion of pseudouridine as an independent prognostic factor in renal cell carcinoma
    T Rasmuson
    Department of Oncology, University Hospital, , Sweden
    Acta Oncol 30:11-5. 1991
    ..The level of pseudouridine correlated to tumor grade and tumor size. Using Cox's proportional hazard model, only clinical stage and level of pseudouridine excretion were independent predictors of prognosis...
  31. ncbi request reprint Similar rates of exponential decrease in serum concentrations of free prostate-specific antigen (PSA), PSA complexed to alpha-1-antichymotrypsin, and human glandular kallikrein 2 (hK2) in prostate cancer patients treated with GnRH-analogues
    T Bjork
    Department of Urology, Malmö and Lund University Hospitals, Lund University, Malmo, Sweden
    Prostate 47:14-20. 2001
    ..In addition, serum concentrations of hK2, the activator of proPSA, were measured...
  32. doi request reprint An image analysis method for prostate tissue classification: preliminary validation with resonance sensor data
    P L Lindberg
    Department of Applied Physics and Electronics, Umea University, Umea, Sweden
    J Med Eng Technol 33:18-24. 2009
    ..001). Thus it can be concluded that there existed a linear relationship between the impression depth and the tissue classes. The new image analysis method was easy to handle and decreased the classification time by 80%...